Fresenius SE & Co KGaA
Fresenius SE & Co KGaA operates as a global healthcare group providing hospital services, medical products, and dialysis care, generating revenue through service fees and product sales.
Business. Fresenius SE & Co KGaA (FREG.DE) is a company engaged in the exploration and production of oil and gas. The firm operates within the Oil & Gas industry, generating revenue through product sales. It is primarily listed on the Xetra exchange. Specific details regarding operating segments and geographic distribution are not available.
Analyst recommendations
18 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Fresenius SE & Co KGaA (FREG.DE) is a company engaged in the exploration and production of oil and gas. The firm operates within the Oil & Gas industry, generating revenue through product sales. It is primarily listed on the Xetra exchange. Specific details regarding operating segments and geographic distribution are not available.
Fresenius maintains a leveraged capital structure with total liabilities of €22.3 billion against total equity of €19.1 billion, resulting in a debt-to-equity ratio of 0.62. The company holds €111 million in cash and equivalents, which is insufficient to cover its €11.8 billion in long-term debt, creating a net cash deficit. Liquidity is supported by a current ratio of 1.32, indicating adequate short-term asset coverage for current liabilities. Operating cash flow stands at €2.57 billion, while free cash flow is €545 million after capital expenditures of €1.49 billion.
Profitability metrics show a return on equity of 7.69% and a return on assets of 3.55%. The company generated €22.87 billion in revenue, with a gross profit of €5.69 billion and operating income of €2.31 billion. Net income reached €1.26 billion. Without cohort median data provided in the input, these returns are assessed in isolation, showing modest leverage-adjusted profitability.
- Fresenius generates €22.87 billion in revenue with €1.26 billion in net income, yielding a 7.69% ROE.
- The company carries €11.8 billion in long-term debt against €111 million in cash, resulting in a negative net cash position.
- Liquidity is moderate with a current ratio of 1.32 and operating cash flow of €2.57 billion.
- Analyst sentiment is positive with a mean recommendation of 1.61 and a median price target of €54.00.
- Dilution risk is low with no difference between basic and diluted share counts.
Bull / Bear case
Generated · model-assistedAnalysts project 37.7% upside to a mean price target of EUR 53.42, reflecting strong buy consensus among 18 analysts.
Net income surged 168.4% year-over-year to EUR 1.26 billion in FY2026, demonstrating significant profitability recovery.
Long-term debt decreased substantially to EUR 11.83 billion in FY2026, improving the balance sheet from EUR 27.16 billion in FY2022.
Cash conversion ratio of 1.75 exceeds the cohort median of 1.22, indicating superior efficiency in generating cash from earnings.
Operating income grew 11.4% year-over-year to EUR 2.31 billion in FY2026, signaling expanding operational profitability.
The company faces high credit risk, posing a significant threat to financial stability and potential borrowing costs.
In focus — financials by report
Revenue €5.82B, +2,0% YoY; Operating income −12,6% YoY.
- ▍Revenue €5.82B, +2,0% YoY
- ▍Operating income −12,6% YoY
- ▍Net income +90,0% YoY
- ▍Free cash flow +7,3% YoY
- ▍Net margin 7.5%
Revenue €6.16B, +5,2% YoY; Operating income +40,5% YoY.
- ▍Revenue €6.16B, +5,2% YoY
- ▍Operating income +40,5% YoY
- ▍Net income +50,4% YoY
- ▍Free cash flow −91,8% YoY
- ▍Net margin 5.9%
Revenue €5.49B, +3,2% YoY; Operating income −4,9% YoY.
- ▍Revenue €5.49B, +3,2% YoY
- ▍Operating income −4,9% YoY
- ▍Net income +5,5% YoY
- ▍Free cash flow −14,2% YoY
- ▍Net margin 6.3%
Revenue €5.58B, +2,6% YoY; Operating income +0,2% YoY.
- ▍Revenue €5.58B, +2,6% YoY
- ▍Operating income +0,2% YoY
- ▍Net income +188,5% YoY
- ▍Free cash flow −159,0% YoY
- ▍Net margin 5.9%
Revenue €5.71B; Operating income €689.0M.
- ▍Revenue €5.71B
- ▍Operating income €689.0M
- ▍Net margin 4.0%
Revenue €5.85B; Operating income €425.0M.
- ▍Revenue €5.85B
- ▍Operating income €425.0M
- ▍Net margin 4.1%
Revenue €5.32B; Operating income €490.0M.
- ▍Revenue €5.32B
- ▍Operating income €490.0M
- ▍Net margin 6.1%
Revenue €5.44B; Operating income €559.0M.
- ▍Revenue €5.44B
- ▍Operating income €559.0M
- ▍Net margin -6.9%
Revenue €22.87B, +4,2% YoY; Operating income +11,4% YoY.
- ▍Revenue €22.87B, +4,2% YoY
- ▍Operating income +11,4% YoY
- ▍Net income +168,4% YoY
- ▍Free cash flow −59,7% YoY
- ▍Net margin 5.5%
Revenue €21.95B, +4,2% YoY; Operating income +75,2% YoY.
- ▍Revenue €21.95B, +4,2% YoY
- ▍Operating income +75,2% YoY
- ▍Net income +179,3% YoY
- ▍Free cash flow +990,1% YoY
- ▍Net margin 2.1%
Revenue €21.07B, −2,2% YoY; Operating income −34,7% YoY.
- ▍Revenue €21.07B, −2,2% YoY
- ▍Operating income −34,7% YoY
- ▍Net income −143,3% YoY
- ▍Free cash flow −137,0% YoY
- ▍Net margin -2.8%
Revenue €21.53B, −42,6% YoY; Operating income −56,4% YoY.
- ▍Revenue €21.53B, −42,6% YoY
- ▍Operating income −56,4% YoY
- ▍Net income −24,5% YoY
- ▍Free cash flow −78,7% YoY
- ▍Net margin 6.4%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 3,55 |
| Revenue | —no estimate | —no estimate | 23,6B EUR |
| Operating income | —no estimate | —no estimate | 2,7B EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Physical assets
2 tracked| Asset | Type | Commodity | Country | Role |
|---|---|---|---|---|
| St. Wendel power station | Power | Power | Germany | Parent |
| St. Wendel power station | Power | Oil & Gas | Germany | Parent |
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Cash Conversion Ratiooperating_cash_flow / net_income
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Return On Assetsnet_income / total_assets
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Fresenius SE & Co KGaA Market data — financials · 2026-07-07
- Fresenius SE & Co KGaA Market data — analyst estimates · 2026-07-07
- Fresenius SE & Co KGaA Market data — ESG · 2026-07-07
- Fresenius SE & Co KGaA — company reference export (2026-07-05) · 2026-07-07